Related Experiment Video
Updated: Feb 10, 2026
04:51
Author Spotlight: Efficient CRISPR/Cas9 Genome Editing in Bone Marrow-Derived Macrophages for Precise Gene Disruption
Published on: August 4, 2023
2.3K
Erythrocyte membrane based cationic polymer-mcDNA complexes as an efficient gene delivery system
Ping Huang1, Jing Zhao1, Chiju Wei2
1Center for Gene and Cell Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China. zy.chen1@siat.ac.cn.
Biomaterials Science
|November 29, 2016
Summary
This study introduces a novel gene delivery system using erythrocyte membranes and cationic polymers. This innovative vehicle demonstrates high efficiency and low toxicity, offering a promising solution for gene therapy applications.
Area of Science:
- Biotechnology
- Gene Therapy
- Nanomedicine
Background:
- Gene therapy holds significant potential for treating genetic diseases.
- Current limitations in safe and efficient gene delivery hinder clinical translation.
- Developing advanced gene delivery vehicles is crucial for therapeutic success.
Purpose of the Study:
- To develop and evaluate a novel gene delivery system.
- To assess the efficiency and cytotoxicity of the new system.
- To investigate the mechanism of cellular uptake for the gene vector.
Main Methods:
- Constructed a gene delivery vehicle using erythrocyte membranes and cationic polymers (e.g., XtremeGENE, ε-caprolactone modified polyethylenimine).
- Evaluated gene delivery efficiency and cytotoxicity in various cell lines (293T, Huh7, HepG2, DC2.4, Hu-MSCs).
- Utilized confocal laser scanning microscopy and flow cytometry to analyze cellular uptake.
Main Results:
- The erythrocyte membrane-based system exhibited high gene delivery efficiency.
- The novel system demonstrated negligible cytotoxicity compared to cationic polymers alone.
- Enhanced cellular uptake was observed, potentially via membrane fusion mechanisms.
Conclusions:
- The erythrocyte membrane-based gene delivery system shows promise as an effective and safe therapeutic tool.
- This innovative vector overcomes limitations of traditional gene delivery methods.
- Further research into this system could advance clinical gene therapy applications.
More Related Videos
Related Concept Videos
02:34Polymers
41.1K
The word polymer is derived from the Greek words “poly” which means “many” and “mer” which means “parts”. Polymers are long chains of molecules composed of repeating units of smaller molecules, known as monomers. They either occur naturally, such as DNA and proteins, or can be constructed synthetically, like plastics. They have varied structural characteristics, such as linear chains, branched chains, or complex networks, that contribute to the...
41.1K
02:34Polymers
23.4K
No description available
23.4K
01:22Lifecycle of Erythrocytes
5.4K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.4K
01:27Disorders of Erythrocytes
2.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
01:29Structure and Function of Erythrocytes
6.1K
There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
6.1K
01:57Protein Complexes with Interchangeable Parts
2.9K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K